151
Views
3
CrossRef citations to date
0
Altmetric
Original Article

A survey of physicians’ attitudes toward uterotonic administration in parturients undergoing cesarean section

, , , , , & show all
Pages 3183-3190 | Received 12 May 2017, Accepted 09 Aug 2017, Published online: 23 Aug 2017

References

  • Wilkinson H. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. BJOG. 2011;118(11):1402–1403. discussion:3–4.
  • Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol. 2010;202(4):353.e1–353.e6.
  • Fett JD. Pregnancy-related mortality due to cardiomyopathy: United States, 1991–1997. Obstet Gynecol. 2004;103:1342. Author reply:3.
  • Jardine JE, Law P, Hogg M, et al. Haemorrhage at caesarean section: a framework for prevention and research. Curr Opin Obstet Gynecol. 2016;28(6):492–498.
  • Briley A, Seed PT, Tydeman G, et al. Reporting errors, incidence and risk factors for postpartum haemorrhage and progression to severe PPH: a prospective observational study. BJOG. 2014;121(7):876–888.
  • Bateman BT, Berman MF, Riley LE, et al. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368–1373.
  • Onyi Onuoha RG Obstetric anesthesia, An issue of anesthesiology clinics. 1st ed. Vol. 35–1. New York: Elsevier; 2017.
  • Dahlke JD, Mendez-Figueroa H, Maggio L, et al. Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines. Am J Obstet Gynecol. 2015;213(1): 76.e1–76.10.
  • Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section – a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol. 2008;137(1):27–30.
  • Sheehan SR, Wedisinghe L, Macleod M, et al. Implementation of guidelines on oxytocin use at caesarean section: a survey of practice in Great Britain and Ireland. Eur J Obstet Gynecol Reprod Biol. 2010;148(2):121–124.
  • ACOG. ACOG Practice Bulletin: clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108(4):1039–1047.
  • Postpartum Haemorrhage, Prevention and Management (Green-Top Guideline no. 52). Royal College of Obstetricians and Gynaecologists; 2017. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg52/.
  • Caesarean section: Guidance and guidelines. NICE; 2011.
  • Butwick AJ, Coleman L, Cohen SE, et al. Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth. 2010;104(3):338–343.
  • George RB, McKeen D, Chaplin AC, et al. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing cesarean delivery. Can J Anesth. 2010;57(6):578–582.
  • Balki M, Tsen L. Oxytocin protocols for cesarean delivery. Int Anesthesiol Clin. 2014;52(2):48–66.
  • Tsen LC, Balki M. Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio? Int J Obstet Anesth. Netherlands. 2010;19(3):243–245.
  • Kovacheva VP, Soens MA, Tsen LC. A randomized, double-blinded trial of a “Rule of Threes” algorithm versus continuous infusion of oxytocin during elective cesarean delivery. Anesthesiology. 2015;123(1):92–100.
  • Central Intelligence Agency. The World Factbook Central Intelligence Agency 2016. Available from: https://www.cia.gov/library/publications/the-world-factbook/rankorder/2127rank.html.
  • Weiniger CF, Ivri S, Ioscovich A, et al. Obstetric anesthesia units in Israel: a national questionnaire-based survey. Int J Obstet Anesth. 2010;19(4):410–416.
  • Marcus HE, Fabian A, Lier H, et al. Survey on the use of oxytocin for cesarean section. Minerva Anestesiol. 2010;76(11):890–895.
  • Butwick AJ, Carvalho B, El-Sayed YY. Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery. Br J Anaesth. 2014;113(4):661–668.
  • Duffield A, McKenzie C, Carvalho B, et al. Effect of a high-rate versus a low-rate oxytocin infusion for maintaining uterine contractility during elective cesarean delivery: a prospective randomized clinical trial. Anesth Analg. 2017;124(3):857–862.
  • Carvalho JC, Balki M, Kingdom J, et al. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104(5 Pt 1):1005–1010.
  • West R, West S, Simons R, et al. Impact of dose-finding studies on administration of oxytocin during caesarean section in the UK. Anaesthesia. 2013;68(10):1021–1025.
  • Thomas TA, Cooper GM, Editorial Board of the Confidential Enquiries into Maternal Deaths in the United Kingdom. Maternal deaths from anaesthesia. An extract from Why mothers die 1997–1999, the Confidential Enquiries into Maternal Deaths in the United Kingdom. Br J Anaesth. 2002;89(3):499–508.
  • Pinder AJ, Dresner M, Calow C, et al. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth. 2002;11(3):156–159.
  • Svanström MC, Biber B, Hanes M, et al. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and Methylergometrine during caesarean section. Br J Anaesth. 2008;100(5):683–689.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.